BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:36 PM
 | 
Feb 21, 2008
 |  BC Extra  |  Company News

FDA accepts milnacipran NDA

FDA accepted an NDA from Forest (NYSE:FRX) and Cypress (NASDAQ:CYPB) for milnacipran to treat fibromyalgia. The companies expect a decision by...

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >